Trials / Recruiting
RecruitingNCT05584566
Ridge Augmentation Treatment Using OSSIX® BREEZE vs Jason®
Ridge Augmentation Treatment Using OSSIX® BREEZE vs Jason® Membrane in Simultaneous Implantations. A Prospective, Randomized Controlled Trial.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- Sponsor
- Datum Dental LTD · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective randomized controlled parallel trial. The aim of this study is to evaluate bone formation and soft tissue healing after 4 and 8 months in patients with ridge deficiencies in simultaneous implantation approach. The trial will compare a (sugar cross linked) - SCL pericardium membrane OSSIX® Breeze vs native pericardium membrane (Jason®).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OSSIX Breeze | barrier membrane |
| DEVICE | Jason membrane | barrier membrane |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
- First posted
- 2022-10-18
- Last updated
- 2024-10-16
Locations
3 sites across 2 countries: Israel, United Kingdom
Source: ClinicalTrials.gov record NCT05584566. Inclusion in this directory is not an endorsement.